Umbilical cord milking does not appear to escalate risk of neurodevelopmental delay in non-vigorous infants: Research

Umbilical cord milking, a treatment for non-vigorous newborns, involves transferring blood from the umbilical cord to improve their condition without increasing neurodevelopmental risks, according to a NIH-funded study of nearly 1,000 full-term and near-term infants. It was compared to early cord clamping, standard for immediate resuscitation.

Previous concerns about brain injury in preterm infants prompted this study focusing on term infants, affirming umbilical cord milking's safety. Non-vigorous infants, at risk for low brain oxygen, cerebral palsy, and stroke, typically undergo immediate cord clamping for resuscitation. Conversely, delaying clamping benefits vigorous term infants by enhancing haemoglobin and iron levels.

Researchers evaluated developmental screening and autism risk in surviving infants. Scores for both tests showed no significant difference between the umbilical cord milking and early clamping groups. Previous findings also highlighted benefits like reduced need for respiratory support and increased blood flow.

In conclusion, umbilical cord milking appears reasonable for non-vigorous full-term and near-term infants, offering potential benefits without added neurodevelopmental risks.